Hemolytic Uremic Syndrome: INM004 Treatment for Kids

We are studying a new treatment for children with Hemolytic Uremic Syndrome caused by E. coli to see if it helps improve kidney function and reduce complications. The trial will also evaluate the safety of this treatment.

6-12 months 6-10 visits Confirmation phase (III)Cost Reimbursement Investigational Medicines InjectionInfectious DiseasesNephrologyPediatrics

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Sodium Chloride Solution 0.9%

Sodium chloride 0.9% is a sterile salt solution used to replace fluids and electrolytes, hydrate patients, and clean wounds or body cavities.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Anti Shiga Toxin

Equine Immunoglobulin F(ab')2 Fragments Targeting Shiga Toxin

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Cliniques Universitaires Saint-Luc

Pediatrics

Sint-Stevens-Woluwe, Belgium

CHU De Bordeauxt

Pediatric Nephrology Unit

Bordeaux, France

Hospices Civils De Lyon

Pediatric nephrology-rheumatology-dermatology department

Bron, France

Sponsor: Chemo Research S.L.

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.